iBio, Inc.
IBIO· Nasdaq
IBIOiBio, Inc.
Filed Feb 19, 2013 · 10-Q · 50 days after period end · 0000930413-13-000942
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Revenue | $0.00 | $233.83K | — |
| Net Income | -$1.07M | -$1.60M | -$4.71M |
| EPS Diluted | -$0.02 | -$0.05 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Feb 19, 2013 · 50 d after period end
